7:31 am Amicus Therapeutics highlights data – encouraging additional post-hoc analyses of interim data from Phase 3 Fabry Monotherapy Study 011
View todays social media effects on FOLD
View the latest stocks trending across Twitter. Click to view dashboard
See who Amicus is hiring next, click here to view
